Clinical Trials Browser

Biliary Tract Neoplasms, Cholangiocarcinoma

Thyroid Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Dysplastic Nevus Syndrome, Melanoma, Hereditary Sensory and Autonomic Neuropathies

Carcinoma, Renal Cell

Melanoma, Skin Neoplasms

Squamous Cell Carcinoma of Head and Neck

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Melanoma, Motor Activity

Carcinoma, Non-Small-Cell Lung, Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasms

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

Lung Diseases, Interstitial

Carcinoma, Hepatocellular, Liver Diseases

Brain Neoplasms

Diabetes Mellitus

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Triple Negative Breast Neoplasms

Melanoma, Neoplasms

Neoplasm Metastasis

Kidney Neoplasms, Lung Neoplasms, Melanoma

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Uncommon Pathological Types of Lung Cancer

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Advanced Colorectal Carcinoma

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Lung Squamous Cell Carcinoma Stage IV

Clinical Trials

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

NeoLATC

ALCG-01

Oncomabs

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

International Multicentric Study ARON-1

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

APiTOXMM

Imaging FDG Flare in Melanoma

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4]

EROS

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

TREATMENT

NSCLC

I-STOP

Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

PORTRAIT

PASIP

ST-ICI

Microbiome Immunotherapy Toxicity and Response Evaluation

QUASAR

PROBES

Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients

Esporta

Immunotherapy in Lung Cancer: Treatment After IO Cessation.

A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients

Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer

Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

A Survival Observational Study in Patients With Advanced IIIB-IV Squamous Cell Lung Cancer Receiving PD-1 Combination With Chemotherapy